Report overview
Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen.
This report aims to provide a comprehensive presentation of the global market for Idiopathic Pulmonary Fibrosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idiopathic Pulmonary Fibrosis. This report contains market size and forecasts of Idiopathic Pulmonary Fibrosis in global, including the following market information:
Global Idiopathic Pulmonary Fibrosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Idiopathic Pulmonary Fibrosis market was valued at US$ 1781.8 million in 2022 and is projected to reach US$ 3276.3 million by 2029, at a CAGR of 9.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
An increase in the incidence and prevalence of fibrotic diseases is the primary driver for the growth of this market. Idiopathic pulmonary fibrosis most commonly affects middle-aged to older adults and is characterized by the scarring of lung tissues. In older people, these scars tend to build up and affect the normal functioning of lungs. Thus, an increase in aging population leads to increased prevalence of the disease, which in turn results in market growth during the predicted period.
We surveyed the Idiopathic Pulmonary Fibrosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Idiopathic Pulmonary Fibrosis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Idiopathic Pulmonary Fibrosis Market Segment Percentages, by Type, 2022 (%)
Systemic Corticosteroids
Immunosuppressant Drugs
Tyrosine Kinase Inhibitors
Antifibrotic Agents
Global Idiopathic Pulmonary Fibrosis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Idiopathic Pulmonary Fibrosis Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Academic and Research Organizations
Global Idiopathic Pulmonary Fibrosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Idiopathic Pulmonary Fibrosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Idiopathic Pulmonary Fibrosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Idiopathic Pulmonary Fibrosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
MediciNova
Boehringer Ingelheim
F. Hoffmann-La Roche
FibroGen
Promedior
Merck
Galapagos
Prometic Life Sciences
Cipla
Outline of Major Chapters:
Chapter 1: Introduces the definition of Idiopathic Pulmonary Fibrosis, market overview.
Chapter 2: Global Idiopathic Pulmonary Fibrosis market size in revenue.
Chapter 3: Detailed analysis of Idiopathic Pulmonary Fibrosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Idiopathic Pulmonary Fibrosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
